HEPA cult was founded as a spin-off of the University Hospital Regensburg into being in the year of 2002. The founding team has developed a technology platform for the isolation and preservation of human liver cells and established. From this knowledge base of the company a number of innovative products and services for the research-based pharmaceutical industry and publicly funded research institutions are generated.

Human liver cells for Applied Sciences and Pharmaceutical Research

hepa cult provides in vitro to systems that are derived from human liver tissue. The liver is the central Verstoffwechslungsorgan for drugs. Only with cells from the human liver, the effect of a drug on humans can be tested satisfactorily. Hepa cult is a supplier and service provider for the pharmaceutical industry and the scientific community. Hepa cult permits in some areas the abandonment of animal testing, reduced the risk of new drugs and provides research high-quality, state-of-the-art models. Innovative technologies protect the donor material HEPA cult used preservation techniques which do not adversely affect the quality of the material. hepa cult wants long term humane through constant technological improvements liver cells as in vitro model under provide standardized and validated conditions for scientific use. Regenerative medicine and new therapies hepa cult seeks to gradually open up new fields of application for its proprietary technologies. Here the developed know-how is transferred to other body tissues and body organs. Hepa cult works in research projects with partners on innovative concepts for a regeneration of liver tissue and to novel therapeutic strategies, for. Example, in the field of Gastro Tere Logie, Hepatology, virology and transplantation medicine.